Show simple item record

dc.contributor.authorSAYIN, U
dc.contributor.authorWESTERINK, BHC
dc.contributor.authorTIMMERMAN, W
dc.date.accessioned2021-03-05T14:01:12Z
dc.date.available2021-03-05T14:01:12Z
dc.date.issued1995
dc.identifier.citationSAYIN U., TIMMERMAN W., WESTERINK B., "THE SIGNIFICANCE OF EXTRACELLULAR GABA IN THE SUBSTANTIA-NIGRA OF THE RAT DURING SEIZURES AND ANTICONVULSANT TREATMENTS", BRAIN RESEARCH, cilt.669, ss.67-72, 1995
dc.identifier.issn0006-8993
dc.identifier.otherav_b50518cb-7e97-40bc-b925-a8a227fb3ca1
dc.identifier.othervv_1032021
dc.identifier.urihttp://hdl.handle.net/20.500.12627/120553
dc.identifier.urihttps://doi.org/10.1016/0006-8993(94)01240-i
dc.description.abstractThe effects of the anti-epileptic drugs valproic acid and gamma-vinyl-GABA (vigabatrin) on the extracellular content of GABA was determined by microdialysis. Probes were implanted in the substantia nigra reticulata (SNR) of rats. It was found that gamma-vinyl-GABA (1000 mg/kg) induced a 4-6-fold increase in the extracellular content of GABA. This increase lasted for at least 72 h. PTZ-induced convulsions were partly antagonized by the GVG treatment. The increase of extracellular GABA after gamma-vinyl-GABA was not affected by infusion of tetrodotoxin. In contrast valproic acid (200 mg/kg), although effective in preventing pentylenetetrazol (PTZ)-induced convulsions, did not affect extracellular GABA in the SNR. PTZ-induced convulsions did not modify extracellular GABA, neither in control rats nor in valproic acid or gamma-vinyl-GABA pretreated animals. The results do not support the idea that extracellular GABA in the SNR plays a significant role in anti-convulsive treatment. However, the present data can also be interpreted that extracellular GABA, as sampled by microdialysis, is not a reliable marker for GABA release.
dc.language.isoeng
dc.subjectYaşam Bilimleri (LIFE)
dc.subjectTemel Bilimler
dc.subjectNEUROSCIENCES
dc.subjectSinirbilim ve Davranış
dc.subjectYaşam Bilimleri
dc.titleTHE SIGNIFICANCE OF EXTRACELLULAR GABA IN THE SUBSTANTIA-NIGRA OF THE RAT DURING SEIZURES AND ANTICONVULSANT TREATMENTS
dc.typeMakale
dc.relation.journalBRAIN RESEARCH
dc.contributor.department, ,
dc.identifier.volume669
dc.identifier.issue1
dc.identifier.startpage67
dc.identifier.endpage72
dc.contributor.firstauthorID115931


Files in this item

FilesSizeFormatView

There are no files associated with this item.

This item appears in the following Collection(s)

Show simple item record